Fritextsökning
Innehållstyper
-
Facebookanvändare har mer hjärnminne
Personer som har många vänner på Facebook har också en större amygdala, den del av hjärnan som hanterar minne och känslor. Det visar en ny studie.
-
Clinical trials in large scale to Stockholm
Karolinska Trial Alliance, KTA, will open a medical clinical for clinical trials in Phases II-IV. The clinic will be able to accommodate up to 150 patients per ...
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
Recipharm kammar hem entreprenörtitel
Lars Backsell och Thomas Eldered representerar Stockholm i Sverigefinalen.
-
Grape extract kills cancer cells
Grapes contain potentially beneficial chemicals that can destroy cancer cells, a new research proves.
-
New study of toxins and heart disease
Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study...
-
Stärker ledningen
Lundabaserade A1M Pharma skaffar ny affärsutvecklingschef.
-
Oasmia gets a confirmation
FDA has granted Oasmia an expedited review status for Paclical Vet.
-
New Nordic nutrition collaboration
Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.
-
En CRO-veteran fyller år
Från början byggdes företaget kring en enorm kardiologisk klinisk studie. Nu fyller A + Science 20 år och är ett rutinerat CRO-bolag som står på många ben.
-
Hon sköter KI:s internationella samarbeten
Maria Masucci är ny vicerektor för internationella frågor på det medicinska universitetet.
-
Infidelity produces faster sperms
Until now, it has been difficult to prove that fast-swimming sperms have an advantage when it comes to fertilizing an egg.
-
Dry blood DNA storage on a matrix
Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.
-
Future drugs from Amaryllis
A Danish research team has discovered possibolities to extract drugs fro Amaryllis.
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Vattenfall is firing with biomass
Vattenfall will provide Denmark with electricity by means of biomass.
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Sundin ger miljoner till forskning
Finansierar tjänster i Solna och Toronto.
-
Söker triggern till reumatoid artrit
Med hjälp av modern dna-teknik, registerdata från tusentals patienter och samarbeten med industrin hoppas Lars Klareskog nå hela vägen till en bot mot reumatoid...
-
Satsar på USA
Braincool lämnar in en marknadsansökan till FDA och förbereder lansering.
-
Influensaprofylax ok för gravida
Största studien: Barn vars mödrar under graviditet behandlats med läkemedel mot influensa uppvisar ingen ökad risk till ohälsa.
BREAKING